Approval · Notice of Compliance 977 · 2000
SCHEINPHARM AMOXICILLIN: Notice of Compliance 977
Issued March 10, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 977
- Date
- March 10, 2000
- Company
- Schein Pharmaceutical Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- AMOXIL (Wyeth-Ayerst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SCHEINPHARM AMOXICILLIN | 02241826 | Cancelled (Unreturned Annual) |
| SCHEINPHARM AMOXICILLIN | 02241827 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- AMOXICILLIN 250 MG per CAP
- AMOXICILLIN 500 MG per CAP